Cite

HARVARD Citation

    Kerbauy, L. et al. (n.d.). 531 AFM13-targeted blood and cord-blood-derived memory-like NK cells as therapy for CD30+ malignancies. Journal for immunotherapy of cancer. pp. A324-A325. [Online]. 
  
Back to record